TipRanks
Go Ultimate55% OFF

Universal Health (UHS) AI Stock Analysis

MX:UHS

Universal Health

(BMV:UHS)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Broad Patient Volume GrowthBroad-based admissions and emergency department growth indicates durable demand across UHS facilities rather than dependence on one service line. Higher utilization supports revenue absorption of fixed costs, strengthens operating leverage, and provides a foundation for continued growth as recently added capacity ramps.
Negative Factors
Medicaid Reimbursement HeadwindThe expected loss of Medicaid supplemental payments represents a material structural pressure on future earnings, particularly across states and facilities that benefited from prior programs. The magnitude could reduce margin and cash generation, forcing greater reliance on volume, pricing, and efficiency initiatives to offset reimbursement changes.

Universal Health (UHS) vs. SPDR S&P 500 ETF (SPY)

-30%-20%-10%0%10%20%30%MX:UHS-29.16%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
MXN 9.10B
Dividend Yield
0.54%
Average Volume (3M)
―
Price to Earnings (P/E)
7.3
Beta (1Y)
0.22
Revenue Growth
-3.08%
EPS Growth
1.96%
Country
Mexico
Employees
101,500
Sector
Healthcare
Sector Strength
51
Industry
Medical - Care Facilities

Universal Health Business Overview & Revenue Model

Company Description

Universal Health Services, Inc. (UHS), operating through its various divisions, is a healthcare entity that both owns and manages a network of acute care hospitals, along with outpatient and specialized behavioral health treatment centers. Its busine...

Universal Health Earnings Call Summary

Earnings Call Date:Oct 26, 2026(Q3-2026)|% Change Since:0.00%|Next Earnings Date:Mar 02, 2027
Earnings Call SentimentNeutral

The call reflected a mixed but cautiously constructive outlook. UHS reported solid acute care admissions, emergency department visits, behavioral health volumes, cash flow, labor trends, and strategic progress in outpatient access and Talkspace integration. However, these positives were offset by lower adjusted EPS and EBITDA, slower de novo hospital ramps, a decline in surgical volumes, Laurel Ridge losses, exchange-related pressure, and substantial expected Medicaid supplemental payment headwinds. Management reiterated guidance but expects 2026 results toward the lower end of the ranges, making the overall tone balanced.

Positive Updates

Sequential Operating Improvement
Underlying third-quarter performance reflected sequential improvement in several areas: acute care demand remained strong, behavioral health volumes increased relative to recent quarters, labor trends continued to moderate, and expense management remained disciplined.

Negative Updates

Adjusted EPS and EBITDA Decline
Third-quarter adjusted EPS was $5.22, down 8% year over year. Adjusted EBITDA less NCI was $625 million, compared with $671 million in the third quarter of 2025.

Company Guidance

UHS reiterated its financial and operating forecast ranges issued with its second quarter results in July and currently expects results to be towards the lower end of these ranges; it expects Cedar Hill Regional Medical Center to reach operational break even in the first half of 2027, Laurel Ridge Treatment Center recertification during 2027, and facilities incurring operating losses during 2026 of $80 million-$100 million to recover at least a meaningful portion of those losses in 2027. The company estimates a 2027 Medicaid supplemental payments headwind of approximately $175 million-$200 million, including approximately $10 million during the fourth quarter 2027 from the initial provider tax portion of the OB3 funding cuts, while annualizing the second half 2026 exchange run rate would create a $15 million headwind in 2027; it has no estimate for Medicaid work requirements. UHS expects capital expenditures to be slightly below $1 billion for the full-year of 2026 and to moderate towards $800 million beyond 2026, with its acute care growth algorithm at 1.5%-2.5% adjusted admission growth and 2%-3% pricing growth and its behavioral health algorithm at 1%-2% adjusted patient day growth and 2%-3% pricing; Talkspace synergies are expected over the first 12-24 months of ownership, with the transaction expected to be slightly accretive in the first 12 months.

Universal Health Risk Analysis

Universal Health disclosed 32 risk factors in its most recent earnings report. Universal Health reported the most risks in the "Production" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

1 New Risk
1.The success of our acquisition of Talkspace, Inc. is subject to numerous risks and uncertainties.Q2, 2026

Universal Health Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

MX:UHS against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
THCTHC84Outperform$21.75B7.8760.60%―6.23%136.09%
EHCEHC79Outperform$13.41B20.9725.17%0.57%9.36%20.85%
HCAHCA61Neutral$98.85B57.42-100.45%0.65%5.82%16.59%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
ACHCACHC43Neutral$2.79B-2.40-50.02%―4.27%-917.61%
CYHCYH39Underperform$338.46M-0.6236.02%―-7.84%-88.93%

* Healthcare Sector Average

Performance Comparison

-25%0%25%50%MX:UHSACHCCYHHCAEHCTHCDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
MX:UHS and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
MX:UHSUniversal Health Services2539.00-1045.15-29.16%
ACHCAcadia Healthcare Company, Inc.29.968.6540.59%
CYHCommunity Health Systems2.40-1.45-37.66%
HCAHca Healthcare473.1914.773.22%
EHCEncompass Health135.9020.6817.95%
THCTenet Healthcare Corp.273.2571.8635.68%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.